Univercells Company

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%. Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.

Founded Date: 2013-01-01
Last Funding Type: Venture - Series Unknown
Headquarters: Gosselies, Hainaut, Belgium
Investors Number: 10
Technology: Others
Employee Number: 11-50
Industry: Biotechnology, Health Care, Manufacturing, Science and Engineering
Estimated Revenue: $1M to $10M
Investor Type: For Profit
Total Funding: $94.5M